SecBot SecBot

RVPH

REVIVA PHARMACEUTICALS HOLDINGS, INC.
OTC· Pharmaceutical Preparations· Inc. DE· CIK 0001742927 Biotech & Drug Discovery
$0.3504 −0.00 (−0.80%)
Nov 16 4:00 PM ET · prev $0.3533
Median target
$17.50
+4894% · range $5.00–30.00
Next earnings
Nov 16
today
1 year
−96.4%
from $9.66 · Nov 17
30 days
−22.1%
from $0.4500
52-week range
$0.3325–14.60
−98% from high · low May 15
Avg volume 20D
34.5K
Oct 30 spike 110.1K
Short interest
403.3K
+0.8%
Days to cover
6.7
at average volume
Insider net
$0
no open-market trades · 12 mo
Filing reports
9
analyzed by SecBot
SecBot read MIXED 3 reports · 90 days
Balance 0 bearish · 0 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 3/3

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersNO TRADES

    No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.

  • Short sellersSTEADY

    Short interest +0.8% to 403.3K shares. 6.7 days to cover.

  • TrendDOWNTREND

    23% below its 50-day average.

Who's buying

13F
Top holderSharesValue
TD Waterhouse Canada Inc.625$412.00

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

Last action Apr 2026
12-month targets · 2 analysts

Price is below the lowest target. Median implies +4894%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Apr 8, 2026Maxim Group
DOWNGRADE
DOWNGRADEHold
Mar 31, 2026Roth Capital
MAINTAIN
MAINTAINBuy
Mar 30, 2026Alliance Global Partners
MAINTAIN
MAINTAINBuy
Mar 5, 2026D. Boral Capital
DOWNGRADE
DOWNGRADEHold
Jan 5, 2026Chardan Capital
MAINTAIN
MAINTAINBuy
Dec 23, 2025D. Boral Capital
MAINTAIN
MAINTAINBuy
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
2 drugs tracked · Drug pipeline →
Recent

Insider ledger

Form 4
$0
open-market buys or sells · 12 mo
DateInsiderTypeValue
Mar 18, 2026
Bhat Laxminarayan
President and CEO
Mar 18, 2026
AWARD40,925 sh
Mar 18, 2026
Bhat Laxminarayan
President and CEO
Mar 18, 2026
AWARD109,150 sh
Mar 18, 2026
Prabhu Narayan
Chief Financial Officer
Mar 18, 2026
AWARD40,925 sh

Earnings setup

Estimates
Nov 16
reports today

Revision history: 🔒 Fresh data, subscribers only

PeriodEPS est.Range30D rev.Revenue
Current Q🔒 Fresh data, subscribers only
Next QNoneNoneNo data$0.00
Current FY🔒 Fresh data, subscribers only
Next FY🔒 Fresh data, subscribers only

SecBot reports

9 filings · 3 press releases · 0 bullish · 3 bearish · 6 neutral
All RVPH filing & press-release reports (12)